يعرض 1 - 20 نتائج من 237 نتيجة بحث عن '"EMT Epithelial–mesenchymal transition"', وقت الاستعلام: 0.60s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal

    المساهمون: INSERM UMRS 935, INSERM UMRS-MD 1197, Université Paris-Saclay, Génétique Animale et Biologie Intégrative (GABI), AgroParisTech-Université Paris-Saclay-Institut National de Recherche pour l’Agriculture, l’Alimentation et l’Environnement (INRAE), INSERM U542, Hôpital Paul Brousse, Ontogenese de l'Hematopoiese, Université Paris-Sud - Paris 11 (UP11)-Institut National de la Santé et de la Recherche Médicale (INSERM), Interactions cellules souches-niches : physiologie, tumeurs et réparation tissulaire (SToRM), Service de Santé des Armées-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay, Interactions cellules souches-niches : physiologie, tumeurs et réparation tissulaire, Université Paris-Sud - Paris 11 (UP11)-Service de Santé des Armées-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut National de la Sante et de la Recherche Medicale (Inserm)University Paris-SaclayChina Scholarship Council - Plan Cancer of the French National Cancer Institute (INCa) through the ATIP-Avenir program

    المصدر: ISSN: 1661-6596.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/34065633; PUBMED: 34065633; WOS: 000662000700001

  3. 3
    Academic Journal

    المساهمون: University of Sheffield Sheffield, University of East Anglia Norwich (UEA), Università degli Studi di Ferrara = University of Ferrara (UniFE), Institut de Cancérologie de l'Ouest Angers/Nantes (UNICANCER/ICO), UNICANCER, Norwich University

    المصدر: ISSN: 2212-1374 ; Journal of Bone Oncology ; https://inserm.hal.science/inserm-03878089 ; Journal of Bone Oncology, 2021, 31, pp.100398. ⟨10.1016/j.jbo.2021.100398⟩.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/35340569; inserm-03878089; https://inserm.hal.science/inserm-03878089; https://inserm.hal.science/inserm-03878089/document; https://inserm.hal.science/inserm-03878089/file/1-s2.0-S2212137421000531-main.pdf; PUBMED: 35340569; PUBMEDCENTRAL: PMC8948168

  4. 4
  5. 5
  6. 6
    Academic Journal
  7. 7
    Academic Journal

    المساهمون: Santoro, Angela, Bufo, Pantaleo, Russo, Giuseppe, Cagiano, Simona, Papagerakis, Silvana, Bucci, Paolo, Aquino, Gabriella, Longo, Francesco, Feola, Antonia, Giordano, Antonio, Di Carlo, Angelina, Di Domenico, Marina, Pannone, Giuseppe

    وصف الملف: ELETTRONICO

    Relation: info:eu-repo/semantics/altIdentifier/pmid/26218314; info:eu-repo/semantics/altIdentifier/wos/WOS:000546154900001; volume:21; issue:8; firstpage:667; lastpage:674; numberofpages:8; journal:CANCER BIOLOGY & THERAPY; http://hdl.handle.net/11573/837244; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85087179048

  8. 8
    Academic Journal

    وصف الملف: application/pdf

    Relation: Ministerio de Economía y Competitividad PI12/01226; Frontiers in Oncology; Vol. 10 (november 2020); https://ddd.uab.cat/record/253117; urn:10.3389/fonc.2020.594023; urn:oai:ddd.uab.cat:253117; urn:pmcid:PMC7667288; urn:pmc-uid:7667288; urn:pmid:33224888; urn:oai:pubmedcentral.nih.gov:7667288; urn:oai:egreta.uab.cat:publications/ea2a349d-25b1-4fef-845f-980aece8ad68

  9. 9
    Dissertation/ Thesis
  10. 10
  11. 11

    المصدر: Acta Pharmaceutica Sinica B, Vol 11, Iss 10, Pp 3262-3271 (2021)
    Acta Pharmaceutica Sinica. B

  12. 12

    المصدر: Acta Pharmaceutica Sinica B, Vol 11, Iss 9, Pp 2783-2797 (2021)
    Acta Pharmaceutica Sinica. B

    مصطلحات موضوعية: MSC, mesenchymal stem cells, MDSCs, myeloid-derived suppressor cells, Angiogenesis, PDAC, pancreatic ductal adenocarcinoma, Cell, Review, Exosomes, hTERT, human telomerase reverse transcriptase, Metastasis, PCC, pheochromocytoma, HTR, hormone therapy-resistant, 0302 clinical medicine, DNM3, dynamin 3, DC, dendritic cells, miRNA, microRNA, Tumor immunity, CDH3, cadherin 3, NKEXOs, natural killer cell-derived exosomes, PA, phosphatidic acid, CD-UPRT, cytosine deaminase-uracil phosphoribosyltransferase, General Pharmacology, Toxicology and Pharmaceutics, HA, hyaluronic acid, HIF1, hypoxia-inducible factor 1, 0303 health sciences, PS, phosphatidylserine, ECM, extracellular matrix, medicine.anatomical_structure, PGL, paraganglioma, circRNAs, circular RNAs, 030220 oncology & carcinogenesis, CRC, colorectal cancer, MVB, multivesicular body, Drug delivery, APCs, antigen-presenting cells, RCC, renal cell carcinoma, ESCRT, endosomal sorting complex required for transport, Signal transduction, DLBCL, diffuse large B-cell lymphoma, EMT, epithelialmesenchymal transition, ILVs, intraluminal vesicles, HUVECs, human umbilical vein endothelial cells, PD-L1, programmed cell death receptor ligand 1, CCRCC, clear-cell renal cell carcinoma, Del-1, developmental endothelial locus-1, TSG101, tumor susceptibility gene 101, RM1-950, ABCA3, ATP-binding cassette transporter A3, Biology, PI, phosphatidylinositol, 03 medical and health sciences, Immune system, DEXs, DC-derived exosomes, NSCLC, non-small cell lung cancer, MIF, migration inhibitory factor, medicine, PTRF, polymerase I and transcript release factor, 030304 developmental biology, GPC1, glypican-1, SM, sphingomyelin, lncRNAs, long non-coding RNAs, Cancer, NNs, nanoparticles, medicine.disease, TEX, tumor-derived exosomes, Microvesicles, mtDNA, mitochondrial DNA, SNARE, soluble NSF-attachment protein receptor, Drug resistance, lamp2b, lysosome-associated membrane glycoprotein 2b, ncRNA, non-coding RNAs, Cancer research, dsDNA, double stranded DNA, Therapeutics. Pharmacology, HCC, hepatocellular carcinoma, Tumor metastasis, Biomarkers, CAFs, cancer-associated fibroblasts

  13. 13

    المصدر: Computational and Structural Biotechnology Journal
    Computational and Structural Biotechnology Journal, Vol 19, Iss, Pp 4941-4953 (2021)

    مصطلحات موضوعية: Microarray, DFS, disease-free survival, MDSCs, myeloid-derived suppressor cells, AUC, Area under the dose-response curve, Biochemistry, k-NN, K-nearest neighbor, GEP, gene expression profile, Androgen deprivation therapy, Transcriptome, CTLA-4, cytotoxic T-lymphocyte associated protein-4, chemistry.chemical_compound, Prostate cancer, DEmiRs, differentially expressed miRNAs, SCNAs, somatic copy number alterations, Structural Biology, TGFβ, transforming growth factor β, BCR, biochemical recurrence, ICB, immune checkpoint blockade, GEO, Gene Expression Omnibus, NTP, Nearest template prediction, TMB, tumor mutation burden, PD-1, programmed cell death protein-1, NEPC, neuroendocrine prostate cancer, Computer Science Applications, NMF, non-negative matrix factorization, CCLs, cancer cell lines, Tregs, regulatory T cells, miRNAs, EMT, epithelial-mesenchymal transition, mCRPC, metastatic castration-resistant prostate cancer, Biotechnology, Research Article, FDR, false discovery rate, SubMap, Subclass mapping, Molecular subtypes, Biophysics, PCa, prostate cancer, Biology, KEGG, Kyoto Encyclopedia of Genes and Genomes, Olaparib, OS, overall survival, GSEA, Gene Set Enrichment Analysis, microRNA, GO, Gene Ontology, ssGSEA, single-sample gene set enrichment analysis, Genetics, medicine, TNAs, tumor neoantigens, PTEN, miRNAs, microRNAs, IFN, interferon, ADT, androgen deprivation therapy, ComputingMethodologies_COMPUTERGRAPHICS, Taxane, medicine.disease, PD-L1, programmed death-ligand 1, chemistry, Cancer research, biology.protein, TCGA, The Cancer Genome Atlas, MIRcor, miRNA-correlated, AR, androgen receptor, Heterogeneity, TP248.13-248.65, CAFs, cancer-associated fibroblasts

  14. 14

    المؤلفون: Xianqun Fan, Jipeng Li, Muyue Yang, Ping Gu

    المصدر: Bioactive Materials
    Bioactive Materials, Vol 6, Iss 7, Pp 1973-1987 (2021)

    مصطلحات موضوعية: MDSCs, myeloid-derived suppressor cells, medicine.medical_treatment, PLGA, poly(lactic-co-glycolic acid), Cancer immunotherapy, BTK, Bruton's tyrosine kinase, 02 engineering and technology, CAFs, cancer associated fibroblasts, CCL, chemoattractant chemokines ligand, DSF/Cu, disulfiram/copper, melittin-NP, melittin-lipid nanoparticle, IFN-γ, interferon-γ, TNF-α, tumor necrosis factor alpha, ANG2, angiopoietin-2, Hypoxia, lcsh:QH301-705.5, cDCs, conventional dendritic cells, TME, tumor microenvironment, DMXAA, 5,6-dimethylxanthenone-4-acetic acid, HB-GFs, heparin-binding growth factors, M2NP, M2-like TAM dual-targeting nanoparticle, ECM, extracellular matrix, IFP, interstitial fluid pressure, HIF, hypoxia-inducible factor, Tumor microenvironment, PDT, photodynamic therapy, Tregs, regulatory T cells, tdLNs, tumor-draining lymph nodes, 0210 nano-technology, Ab, antibodies, BBB, blood-brain barrier, DMMA, 2,3-dimethylmaleic anhydrid, SA, sialic acid, FDA, the Food and Drug Administration, PS, photosensitizer, Biomedical Engineering, Ag, antigen, Article, PD-1, programmed cell death protein 1, Biomaterials, TAMs, tumor-associated macrophages, lcsh:TA401-492, FAP, fibroblast activation protein, EPR, enhanced permeability and retention, NPs, nanoparticles, MPs, microparticles, NO, nitric oxide, Tumor therapy, scFv, single-chain variable fragment, medicine.disease, IL, interleukin, Radiation therapy, siRNA, small interfering RNA, Nanoparticles, TDPA, tumor-derived protein antigens, lcsh:Materials of engineering and construction. Mechanics of materials, HSA, human serum albumin, RLX, relaxin-2, Bcl-2, B-cell lymphoma 2, PSCs, pancreatic stellate cells, VDA, vasculature disrupting agent, Photodynamic therapy, CaCO3, calcium carbonate, Metastasis, AuNCs, gold nanocages, CTLA4, cytotoxic lymphocyte antigen 4, HPMA, N-(2-hydroxypropyl) methacrylamide, HA, hyaluronic acid, TIM-3, T cell immunoglobulin domain and mucin domain-3, TGF-β, transforming growth factor β, UPS-NP, ultra-pH-sensitive nanoparticle, IBR, Ibrutinib, MCMC, mannosylated carboxymethyl chitosan, α-SMA, alpha-smooth muscle actin, 021001 nanoscience & nanotechnology, VEGF, vascular endothelial growth factor, TAAs, tumor-associated antigens, LPS, lipopolysaccharide, APCs, antigen-presenting cells, Delivery system, DCs, dendritic cells, NF-κB, nuclear factor κB, PHDs, prolyl hydroxylases, EMT, epithelial-mesenchymal transition, TLR, Toll-like receptor, Biotechnology, PFC, perfluorocarbon, 0206 medical engineering, CAP, cleavable amphiphilic peptide, SPARC, secreted protein acidic and rich in cysteine, TfR, transferrin receptor, CTL, cytotoxic T lymphocytes, ODN, oligodeoxynucleotides, nMOFs, nanoscale metal-organic frameworks, ROS, reactive oxygen species, AuNPs, gold nanoparticles, medicine, EPG, egg phosphatidylglycerol, CAR-T, Chimeric antigen receptor-modified T-cell therapy, Chemotherapy, business.industry, AC-NPs, antigen-capturing nanoparticles, TIE2, tyrosine kinase with immunoglobulin and epidermal growth factor homology domain 2, 020601 biomedical engineering, EGFR, epidermal growth factor receptor, LMWH, low molecular weight heparin, PTX, paclitaxel, lcsh:Biology (General), Cancer research, MnO2, manganese dioxide, NK, nature killer, sense organs, business, RBC, red-blood-cell

  15. 15

    المصدر: Regenerative Therapy, Vol 17, Iss, Pp 8-12 (2021)
    Regenerative Therapy

  16. 16

    المؤلفون: Goshi Shiota, Hiroyuki Tsuchiya

    المصدر: Tsuchiya, Hiroyuki. Shiota, Goshi. Immune evasion by cancer stem cells. Regenerative Therapy. 17. 20-33. doi:10.1016/j.reth.2021.02.006
    Regenerative Therapy, Vol 17, Iss, Pp 20-33 (2021)
    Regenerative Therapy

    مصطلحات موضوعية: PD-L1/2, ligands 1/2, 0301 basic medicine, Medicine (General), Immune checkpoint inhibitors, Cell, LAG3, lymphocyte activation gene 3, Review, NK cells, Tumor initiation, HNSCC, head and neck squamous cell carcinoma, MIC, MHC class I polypeptide-related sequence, DC, dendritic cell, 0302 clinical medicine, AML, acute myeloid leukemia, ARID3B, AT-rich interaction domain-containing protein 3B, OCT4, octamer-binding transcription factor 4, TCR, T cell receptor, Cancer stem cells, Immune evasion, CCR7, C–C motif chemokine receptor 7, KDM4, lysine-specific demethylase 4C, medicine.anatomical_structure, TAM, tumor-associated macrophage, EMT, epithelialmesenchymal transition, NK, natural killer, ULBP, UL16 binding protein, LILR, leukocyte immunoglobulin-like receptor, NGF, nerve growth factor, T cells, Biomedical Engineering, Treg, regulatory T cell, Tumor immunity, CTL, cytotoxic T lymphocytes, NOD, nonobese diabetic, Biomaterials, 03 medical and health sciences, R5-920, Immune system, ALDH, alcohol dehydrogenase, EV, extracellular vesicle, MDSC, myeloid-derived suppressor cell, Cancer stem cell, medicine, MHC, major histocompatibility complex, KIR, killer immunoglobulin-like receptor, TAP, transporter associated with antigen processing, SCID, severe combined immunodeficient, QH573-671, business.industry, LMP, low molecular weight protein, CIK, cytokine-induced killer cell, LOX, lysyl oxidase, CTLA-4, cytotoxic T-cell-associated antigen-4, CMV, cytomegalovirus, SOX2, sex determining region Y-box 2, NSG, NOD/SCID IL-2 receptor gamma chain null, Evasion (ethics), CSC, cancer stem cell, 030104 developmental biology, DNMT, DNA methyltransferase, Cancer cell, Immune checkpoints, Cancer research, PI9, protease inhibitor 9, ADCC, antibody-dependent cell mediated cytotoxicity, uPAR, urokinase-type plasminogen activator receptor, Cytology, business, ETO, fat mass and obesity associated protein, 030217 neurology & neurosurgery, PD-1, programmed death receptor-1, PSME3, proteasome activator subunit 3, Developmental Biology

    وصف الملف: application/pdf

  17. 17
  18. 18

    المصدر: Acta Pharmaceutica Sinica B, Vol 11, Iss 2, Pp 309-321 (2021)
    Acta Pharmaceutica Sinica. B

    مصطلحات موضوعية: SRC-3, nuclear receptor coactivator 3, VHL, von Hippel-Lindau tumor suppressor, RRM2, ribonucleotide reductase regulatory subunit M2, KRAS, KRAS proto-oncogene, GTPase, SNAIL1, snail family transcriptional repressor 1, medicine.medical_treatment, CRL, cullin-RING ligase, ERK, mitogen-activated protein kinase 1, NEDD8, NEDD8 ubiquitin like modifier, Review, medicine.disease_cause, JAB1, c-Jun activation domain binding protein-1, p130Cas, BCAR1 scaffold protein, Cas family member, law.invention, Targeted therapy, Degradation, 0302 clinical medicine, Ubiquitin, law, RA, retinoic acid, FBXL3, F-box and leucine rich repeat protein, Ci, cubitus interruptus, Phosphorylation, General Pharmacology, Toxicology and Pharmaceutics, Crosstalk, FBXO3/31, F-box protein 3/31, 0303 health sciences, biology, KEAP1, kelch like ECH associated protein 1, Kinase, Chemistry, KBTBD8, kelch repeat and BTB domain containing 8, CSN, COP9 signalosome, DYRK1A/B, dual-specificity tyrosine-phosphorylation-regulated kinases 1A/B, FBW7, F-box and WD repeat domain containing 7, CDT2, denticleless E3 ubiquitin protein ligase homolog, NRF2, nuclear factor, erythroid 2 like 2, TCN, triciribine hydrate, Cell biology, USP37, ubiquitin specific peptidase 37, Crosstalk (biology), XBP1, X-box binding protein 1, 030220 oncology & carcinogenesis, HCC, hepatocellular carcinomas, Vps34, phosphatidylinositol 3-kinase catalytic subunit type 3, CK1/2, casein kinase I/II, COMMD1, copper metabolism domain containing 1, KLHL3, kelch like family member 3, EMT, epithelialmesenchymal transition, Cullin, P-TEFb, positive transcription elongation factor b, CDK2/4, cyclin dependent kinase 2/4, SPOP, speckle-type POZ protein, AIRE, autoimmune regulator, PYGO2, pygopus 2, TCOF1, treacle ribosome biogenesis factor 1, ID2, inhibitor of DNA binding 2, CHK1, checkpoint kinase 1, Kinases, FZR1, fizzy and cell division cycle 20 related 1, HIF1α, NF-κB and hypoxia inducible factor 1 subunit alpha, EXO1, exonuclease 1, ZBTB16, zinc finger and BTB domain containing 16, NOLC1, nucleolar and coiled-body phosphoprotein 1, 03 medical and health sciences, PKM2, pyruvate kinase M2 isoform, KDM2B, lysine demethylase 2B, PKC, protein kinase C, Cullin-RING ligases, medicine, BMAL1, aryl hydrocarbon receptor nuclear translocator like, ATR, ataxia telangiectasia-mutated and Rad3-related, SOCS6, suppressor of cytokine signaling 6, 030304 developmental biology, PDL1, programmed death ligand 1, HIB, Hedghog-induced MATH and BTB domain-containing protein, AKT, AKT serine/threonine kinase, lcsh:RM1-950, Ubiquitination, TRF1, telomeric repeat binding factor 1, DDB1, damage specific DNA binding protein 1, BCL2, BCL2 apoptosis regulator, CLOCK, clock circadian regulator, MYC, MYC proto-oncogene, bHLH transcription factor, lcsh:Therapeutics. Pharmacology, c-Fos, Fos proto-oncogene, AP-1 transcription factor subunit, RARα, RA receptor α, Tumorigenesis, biology.protein, Suppressor, CRY1, cryptochrome circadian regulator 1, ERG, ETS transcription factor ERG, Carcinogenesis

  19. 19

    المصدر: Acta Pharmaceutica Sinica B, Vol 11, Iss 1, Pp 55-70 (2021)
    Acta Pharmaceutica Sinica. B

    مصطلحات موضوعية: CQ, chloroquine, MSNs, mesoporous silica nanoparticles, Review, Drug resistance, HNSCC, head and neck squamous cell carcinoma, Metastasis, 0302 clinical medicine, MDR, multidrug resistance, CL-siSOX2, cationic lipoplex of SOX2 small interfering RNA, Medicine, ABC, ATP binding cassette, IONP, iron oxide nanoparticle, General Pharmacology, Toxicology and Pharmaceutics, Sali-ABA, 4-(aminomethyl) benzaldehyde-modified Sali, NF-κB, nuclear factor-kappa B, TNBC, triple negative breast cancer, 0303 health sciences, MNP, micellar nanoparticle, Cancer stem cells, Molecular level, BM-MSCs-derived Exos, bone marrow mesenchymal stem cells-derived exosomes, iTEP, immune-tolerant, elastin-like polypeptide, ECM, extracellular matrix, Drug delivery systems, DCLK1, doublecortin-like kinase 1, EpCAM, epithelial cell adhesion molecule, cRGD, cyclic Arg-Gly-Asp, PDT, photodynamic therapy, AFN, apoferritin, 030220 oncology & carcinogenesis, Cancer treatment, Cellular level, CMP, carbonate-mannose modified PEI, Drug delivery, uPAR, urokinase plasminogen activator receptor, Stem cell, GEMP, gemcitabine monophosphate, LNCs, lipid nanocapsules, EMT, epithelialmesenchymal transition, mAbs, monoclonal antibodies, CSCs, cancer stem cells, Nav, navitoclax, PEG-PLA, poly(ethylene glycol)-b-poly(d,l-lactide), Cancer therapy, DQA-PEG2000-DSPE, dequlinium and carboxyl polyethylene glycol-distearoylphosphatidylethanolamine, GLUT1, glucose ligand to the glucose transporter 1, PEG-PCD, poly(ethylene glycol)-block-poly(2-methyl-2-carboxyl-propylene carbonate-graft-dodecanol), Dex, dexamethasone, 03 medical and health sciences, Cancer stem cell, Niche, SSCs, somatic stem cells, Targeting strategies, MB, methylene blue, 030304 developmental biology, business.industry, DLE, drug loading efficiency, lcsh:RM1-950, HH, Hedgehog, PU-PEI, polyurethane-short branch-polyethylenimine, Biomarker, Glu, glucose, medicine.disease, DOX, doxorubicin, SLNs, solid lipid nanoparticles, DDSs, drug delivery systems, Biomarker (cell), EPND, nanodiamond-Epirubicin drug complex, PTX, paclitaxel, PLGA, poly(ethylene glycol)-poly(d,l-lactide-co-glycolide), ALDH, aldehyde dehydrogenase, PBAEs, poly(β-aminoester), lcsh:Therapeutics. Pharmacology, mPEG-b-PCC-g-GEM-g-DC-g-CAT, poly(ethylene glycol)-block-poly(2-methyl-2-carboxyl-propylenecarbonate-graft-dodecanol-graft-cationic ligands), LAC, lung adenocarcinoma, TPZ, tirapazamine, PEG-b-PLA, poly(ethylene glycol)-block-poly(d,l-lactide), Cancer cell, ncRNA, non-coding RNAs, Cancer research, HCC, hepatocellular carcinoma, business, HIF1α, hypoxia-inducible factor 1-alpha, MAPK, mitogen-activated protein kinase, CAFs, cancer-associated fibroblasts

  20. 20

    المؤلفون: Cristiano Rumio, Fabrizio Marcucci

    المصدر: Neoplasia (New York, N.Y.)
    Neoplasia: An International Journal for Oncology Research, Vol 23, Iss 2, Pp 234-245 (2021)

    مصطلحات موضوعية: 0301 basic medicine, PFKFB3, PFKFB isoform 3, Cancer Research, GAPDH, glyceraldehyde 3-phosphate dehydrogenase, OXPHOS, oxidative phosphorylation, ATG, autophagy related, Apoptosis, Drug resistance, Review Article, TKI, tyrosine kinase inhibitor, Oxidative Phosphorylation, 0302 clinical medicine, Neoplasms, Glycolysis, NADPH, nicotinamide adenine dinucleotide phosphate reduced, media_common, LDH, lactate dehydrogenase, Chemistry, ABC, ATP-binding cassette, mTOR, mechanistic target of rapamycin, EMT, TME, tumor microenvironment, PFKFB, phosphofructo-2-kinase/fructose-2,6-biphosphatase, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Cell biology, GLUT, glucose transporter, Mitochondria, HIF, hypoxia-inducible factor, PGK1, PGK isoform 1, ENO, enolase, 030220 oncology & carcinogenesis, Efflux, EMT, epithelial-mesenchymal transition, PI3K, phosphoinositide 3-kinase, Drug, PDK1, PDK isoform 1, ATP, adenosine triphosphate, Epithelial-Mesenchymal Transition, media_common.quotation_subject, DDR, DNA damage repair, HK2, HK isoform 2, PPP, pentose phosphate pathway, Antineoplastic Agents, lcsh:RC254-282, 03 medical and health sciences, ROS, reactive oxygen species, Cell Line, Tumor, PGK, phosphoglycerate kinase, PFKP, PFK platelet type, Animals, Humans, LDHA, LDH isoform A, mAb, monoclonal antibody, Tumors, Tumor microenvironment, Innate immune system, Autophagy, Danger, HK, hexokinase, PDH, pyruvate dehydrogenase, EGFR, epidermal growth factor receptor, Metabolic pathway, 030104 developmental biology, Glucose, Drug Resistance, Neoplasm, PK, pyruvate kinase, PKM2, PK isoform M2, ALDO, fructose biphosphate aldolase, ENO1, ENO isoform 1, Energy Metabolism, PDK, pyruvate dehydrogenase kinase